Table 1.
Gender | Diseases | Trends (1) | Trends (2) | AAPC (95% CI, %) | ||
---|---|---|---|---|---|---|
Year-range | APC (95% CI, %) | Year-range | APC (95% CI, %) | |||
Male | Malignant Tumor | 2000–2007 | 1.8 (0.2–3.4)* | 2007–2017 | − 0.5 (− 1.4–0.4) | 0.4 (− 0.1–0.9) |
Cerebrovascular Disease | 2000–2002 | − 8.4 (− 21.7–7.2) | 2002–2017 | 0.8 (0.1–1.5)* | 0.3 (− 0.3–1.0) | |
Heart Trouble | 2000–2002 | − 7.1 (− 25.2–15.3) | 2002–2017 | 2.7 (1.8–3.6)* | 2.2 (1.4–3.0)* | |
Respiratory Disease | 2000–2010 | − 1.9 (− 3.7– − 0.1)* | 2010–2017 | 0.1 (− 3.0–3.3) | − 1.1 (− 1.9– − 0.4)* | |
Trauma and Toxicosis | 2000–2017 | − 0.5 (− 1.7–0.7) | – | – | − 0.5 (− 1.7–0.7) | |
Female | Malignant Tumor | 2000–2017 | 0.7 (0.1–1.3)* | – | – | 0.7 (0.1–1.3)* |
Cerebrovascular Disease | 2000–2002 | − 5.7 (− 17–7.2) | 2002–2017 | 0.8 (0.2–1.3)* | 0.4 (− 0.1–0.9) | |
Heart Trouble | 2000–2002 | − 6.7 (− 28.9–22.4) | 2002–2017 | 3.2 (2.1–4.4)* | 2.7 (1.8–3.6)* | |
Respiratory Disease | 2000–2009 | − 3.8 (− 6.1– − 1.5)* | 2009–2017 | 0.3 (− 2.5–3.2) | − 1.9 (− 2.9– − 1.0)* | |
Trauma and Toxicosis | 2000–2002 | 9.4 (− 20.8–51.0) | 2002–2017 | − 1.6 (− 2.9– − 0.3)* | − 1.1 (− 2.3–0.2) | |
All | Malignant Tumor | 2000–2008 | 1.7 (0.1 − 3.4)* | 2008–2017 | − 0.5 (− 1.8–0.9) | 0.5 (0.1–1.0)* |
Cerebrovascular Disease | 2000–2002 | − 6.6 (− 19.0–7.7) | 2002–2017 | 0.7 (0.1–1.3)* | 0.3 (− 0.2–0.9) | |
Heart Trouble | 2000–2002 | − 6.7 (− 24.3–15) | 2002–2017 | 2.9 (2.0–3.8)* | 2.4 (1.6–3.1)* | |
Respiratory Disease | 2000–2010 | − 2.4 (− 4.1– − 0.7)* | 2010–2017 | 0.2 (− 2.8–3.3) | − 1.4 (− 2.2– − 0.7)* | |
Trauma and Toxicosis | 2000–2002 | 8.2 (− 21.6–49.3) | 2002–2017 | − 1.2 (− 2.5–0.2) | − 0.7 (− 1.9–0.5) |
APC Annual Percent Change; AAPC Average Annual Percent Change; CI confidence interval.
Significant values are in bold.
*Indicates that AAPC or APC is significantly different from zero at the alpha = 0.05 level.